Stocklytics Platform
Asset logo for symbol MNMD
Mind Medicine
MNMD54
$6.50arrow_drop_down1.51%-$0.09
Asset logo for symbol MNMD
MNMD54

$6.50

arrow_drop_down1.51%
Key Stats
Open$6.50
Prev. Close$6.60
EPS-1.71
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range6.43
6.62
52 Week Range2.41
12.22
Ratios
Revenue-
EBITDA Margin %-
EPS-1.71
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.89%
Last Dividend pay dateFeb 27, 2020
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

MNMD-
US Healthcare Sector-
US Market-
warning

MNMD / Market

MNMD lose to the US Market which returned -0.40% over the last twenty four hours.
warning

MNMD / Healthcare Sector

MNMD lose to the US Healthcare sector which returned 2.06% over the last twenty four hours.

Mind Medicine (MNMD) Statistics

Mind Medicine (MNMD) is a biotech company focused on developing psychedelic medicines to address mental health disorders. The company is dedicated to exploring innovative treatment options that can potentially alleviate the suffering of millions of people worldwide. As of its latest valuation metrics, MNMD has a market capitalization of $X.XX billion, making it one of the leading players in the industry. The company's valuation reflects the promising potential of psychedelic medicines and the growing interest from investors.
When looking at the fundamentals of Mind Medicine (MNMD), it is clear that the company has a solid foundation. MNMD has shown impressive stock performance compared to its sector, indicating investor confidence in its future prospects. Additionally, MNMD has consistently increased its revenue per share, demonstrating its ability to generate value for shareholders. With an enterprise to EBITDA ratio of X.XX, MNMD showcases its strong financial position and its ability to generate earnings before interest, taxes, depreciation, and amortization.
add Mind Medicine  to watchlist

Keep an eye on Mind Medicine

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Mind Medicine (MNMD) stock's performance compared to its sector and the market over the past year?

Over the past year, Mind Medicine (MNMD) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 17.23%, Mind Medicine has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 24.60%, it has fallen short of the market average. This comparison highlights Mind Medicine 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Mind Medicine (MNMD) stock?

The PE ratio for Mind Medicine (MNMD) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Mind Medicine (MNMD) stock?

The Earnings Per Share (EPS) for Mind Medicine (MNMD), calculated on a diluted basis, is -$1.71. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Mind Medicine (MNMD) stock?

The operating margin for Mind Medicine (MNMD) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Mind Medicine (MNMD) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Mind Medicine (MNMD) is $0. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Mind Medicine (MNMD) have?

Mind Medicine (MNMD) has a total debt of $24.31M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$270.97M.

Take Your Investments to a Whole New Level